Sanara MedTech (SMTI)
(Delayed Data from NSDQ)
$27.90 USD
+0.82 (3.03%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $28.12 +0.22 (0.79%) 6:04 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SMTI 27.90 +0.82(3.03%)
Will SMTI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SMTI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SMTI
Down -14.23% in 4 Weeks, Here's Why Sanara MedTech Inc. (SMTI) Looks Ripe for a Turnaround
What Makes Sanara MedTech Inc. (SMTI) a Good Fit for 'Trend Investing'
SMTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SMTI
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
Sanara MedTech Unveils Strategy in Investor Presentation Webcast
Sanara MedTech CEO Steps Down, Agrees to Severance Deal
Sanara MedTech files to sell 255,049 shares of common stock for holders
Sanara MedTech files to sell 255,049 shares of common stock for holders